drugset / Trial / NCT00176410

Statin Therapy in Asymptomatic Aortic Stenosis

NCT00176410

Phase 2 Unknown 100 enrolled University of Leipzig Novartis · collab
RandomizedSingle-groupTriple-blindTreatment

Summary

There is evidence that the degenerative changes leading to aortic stenosis are caused by a chronic inflammatory process. Furthermore the development of aortic stenosis is partially dependent on typical cardiovascular risk factors. An inflammatory process as well as those risk factors are amenable for medical therapy. As such the use of statins (HMG CoA reductase inhibitors) would be an appealing concept to reduce both those risks for development of aortic stenosis. Aim of this study is to evaluate the usefulness of statin therapy on the progression of aortic stenosis.

Timeline

Start
2003-01
Primary completion
2009-09
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified 80 mg

Indications